List of works - Pierre Yves Benhamou

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

scientific article published in 2022

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

scientific article

An Unsafe/Safe Typology in People with Type 2 Diabetes: Bridging Patients’ Expectations, Personality Traits, Medication Adherence, and Clinical Outcomes

scientific article published in 2022

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

scientific article

Applicability and variability of liver stiffness measurements according to probe position

scientific article published on July 2009

Assessment of liver fibrosis: noninvasive means

scientific article published on October 2008

Biomarkers of liver fibrosis

scientific article published on January 2008

Comment on Leelarathna et al. Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes. Diabetes Care 2020;43:e38-e39

scientific article published on 01 October 2020

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers

scientific article

Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

scientific article

Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop study

scientific article published on 09 March 2018

DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial.

scientific article published on 19 April 2018

Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV-hepatitis C virus co-infection

scientific article published in January 2004

Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.

scientific article published in January 2008

Highly unstable type 1 diabetes eligible for islet transplantation can be managed with closed-loop insulin delivery. A series of N-of-1 randomised controlled trials

scientific article published on 01 October 2020

Hirsch index and truth survival in clinical research

scientific article

In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.

scientific article published on June 2004

Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysis

scientific article

Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy

scientific article published in February 2009

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

scientific article

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

scientific article

Ranking hepatologists: which Hirsch's h-index to prevent the "e-crise de foi-e"?

scientific article published on 8 April 2011

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

scientific article published in March 2003

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C

scientific article published on 24 May 2013

The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption

scientific article

Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".

scientific article published on 9 June 2014

List of works by Pierre Yves Benhamou

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

An Unsafe/Safe Typology in People with Type 2 Diabetes: Bridging Patients’ Expectations, Personality Traits, Medication Adherence, and Clinical Outcomes

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

Applicability and variability of liver stiffness measurements according to probe position

Assessment of liver fibrosis: noninvasive means

Biomarkers of liver fibrosis

Comment on Leelarathna et al. Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes. Diabetes Care 2020;43:e38-e39

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers

Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop study

DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial.

Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV-hepatitis C virus co-infection

Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.

Highly unstable type 1 diabetes eligible for islet transplantation can be managed with closed-loop insulin delivery. A series of N-of-1 randomised controlled trials

Hirsch index and truth survival in clinical research

In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.

Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysis

Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

Ranking hepatologists: which Hirsch's h-index to prevent the "e-crise de foi-e"?

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C

The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption

Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".